Drugs and the Liver: High Risk Patients and Transplantation

D. Galmarini

ISBN 10: 9401057486 / ISBN 13: 9789401057486

Published by Springer Netherlands, 2012

About this Item

Druck auf Anfrage Neuware - Printed after ordering - In Drugs and the Liver: High Risk patients and Transplantation, leading physicians, hepatologists, pharmacologists, pathologists and transplant surgeons discuss the most recent advances in the field of liver disease and their treatment. Attention is focused on epidemiology, the diagnosis of disease (clinical chemistry, histopathology, medical imaging analysis), prognosis, prediction, and clinical management. Pathogenesis of diseases such as liver cirrhosis following viral disease or alcohol abuse are discussed at length, and special attention is dedicated to high risk patients (children, fulminant hepatitis). The other major topics include terminal liver failure, for which transplantation is now routine. The latter is discussed in depth, starting from the organ donor management, organ evaluation and preservation, new surgical techniques, post-transplant patient follow-up including side effects of immunosuppression, and reports of the latest drugs used to prevent rejection.

Seller Inventory # 9789401057486

Bibliographic Details

• Title: Drugs and the Liver: High Risk Patients and Transplantation
• Publisher: Springer Netherlands
• Publication Date: 2012
• Language: English
• ISBN 10: 9401057486
• ISBN 13: 9789401057486
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 240W x 160H x 12D millimeters 240 millimeters width by 160 millimeters height by 12 millimeters depth
• Weight: 347 grams

About this title

Synopsis

In Drugs and the Liver: High Risk patients and Transplantation, leading physicians, hepatologists, pharmacologists, pathologists and transplant surgeons discuss the most recent advances in the field of liver disease and their treatment. Attention is focused on epidemiology, the diagnosis of disease (clinical chemistry, histopathology, medical imaging analysis), prognosis, prediction, and clinical management. Pathogenesis of diseases such as liver cirrhosis following viral disease or alcohol abuse are discussed at length, and special attention is dedicated to high risk patients (children, fulminant hepatitis). The other major topics include terminal liver failure, for which transplantation is now routine. The latter is discussed in depth, starting from the organ donor management, organ evaluation and preservation, new surgical techniques, post-transplant patient follow-up including side effects of immunosuppression, and reports of the latest drugs used to prevent rejection.